Cristianne Rijcken | Founder & CSO, Cristal Therapeutics
Cristianne is a serial life science entrepreneur, as apparent from 16+ years strategic and hands-on experience in various biotech companies. With a relentless and creative mindset, Cristianne spearheads startup’s entrepreneurial journeys with primary focus on viable business cases. Hereto, she seamlessly manages the diverse elements from pure R&D to corporate funding, investor relationship, talent acquisition and team growth, intellectual property strategy, business development, strategic assessments and boardroom alignment. She transforms scientific discoveries into commercially successful applications and drives a highly efficient development of innovative drug products to patient evaluation across diverse disease areas. Her core expertise is in nanomedicines in (immune-)oncology; and nowadays also experience with other advanced products in other therapeutic sectors.
As CEO of Liberates, she tackles complex challenges at life science startups with demonstrated ability to articulate long term strategy and focus, propose organizational change, and deliver operational excellence. Cristianne is founder of Cristal Therapeutics, and serves as Chief Scientific Officer of the company. She is inventor of 8 patents, (co-) author of ~ 50 scientific publications, received numerous awards and is invited speaker at various biopharmaceutical conferences.
Cristianne is passionate about the human body and how pharmaceutical compounds can modify (the majority of) its functions, hence beneficially shifting into better health and longevity. She is pharmacist by training, holds a PhD degree in Pharmaceutics from Utrecht University and resides in Maastricht (both The Netherlands).
Powered by: Hyphen Projects BV | Connect with us | Join TOPX | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 | |
|
© Copyright 2020 by Hyphen Projects